Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...

A new “personalised” online tool that predicts the most effective medication for individual patients with type 2 diabetes could benefit millions of people with the condition, researchers have ...

Learn how type 1 and type 2 diabetes differ in causes, onset, and management strategies. Expert insights on symptoms, ...

Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a five-year period and could ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

Medicare prescription drug coverage, such as stand-alone Part D plans and Medicare Advantage drug plans, provides comprehensive coverage for diabetes medications. Original Medicare (parts A and B ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

Millions of people with type 2 diabetes could receive better treatment thanks to a new, simple low-cost tool, according to groundbreaking research announced today at the Diabetes UK Professional ...

Childhood cancer treatments, specifically total body irradiation, were associated with increased risk of developing diabetes among cancer survivors.

Incident type 2 diabetes risk was associated with metabolic syndrome and dyslipidemia especially among patients younger than 55 years of age.